NEUROFIBROMATOSIS
Clinical trials for NEUROFIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells take on nerve tumors: new trial launches
Disease control Recruiting nowThis early-stage trial is testing whether specially engineered immune cells (called CAR-T and CTL cells) and a dendritic cell vaccine can safely treat people with neurofibromatosis or schwannomatosis, conditions that cause nerve tumors. The study will enroll 100 participants aged…
Matched conditions: NEUROFIBROMATOSIS
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a cold sore virus shrink NF1 skin tumors?
Disease control Recruiting nowThis early study tests whether a drug called IMLYGIC, made from a modified herpes virus, can be safely injected into painful or disfiguring skin tumors in adults with NF1. Ten participants will receive up to 8 injections over 4 months. The goal is to see if the treatment is toler…
Matched conditions: NEUROFIBROMATOSIS
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study aims to map neurofibromatosis in russian adults
Knowledge-focused Recruiting nowThis study collects information from 200 adults in Russia who have neurofibromatosis type 1 (NF1) with plexiform neurofibromas. Researchers will look at patients' age, symptoms, and medical history to better understand the disease. No new treatments are being tested; the goal is …
Matched conditions: NEUROFIBROMATOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
NF2 patients wanted for Decade-Long observation study
Knowledge-focused Recruiting nowThis study follows 269 people with neurofibromatosis type 2 (NF2) for up to 10 years to learn how the disease progresses. Participants will have yearly exams, MRI scans, hearing tests, and blood draws. The goal is to understand tumor growth, hearing loss, and speech or swallowing…
Matched conditions: NEUROFIBROMATOSIS
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC